Literature DB >> 7629754

Clinical and differential diagnostic aspects of treatment-resistant depression.

M R Nelsen1, D L Dunner.   

Abstract

This study investigated treatment-resistant depressed patients. A sample of 49 patients was selected from a review of 302 patients who had been consecutively evaluated at a tertiary care facility. Clinical records of these 49 patients revealed frequent misdiagnosis of depression subtype, relatively infrequent treatment with electroconvulsive therapy, and pharmacotherapy trials which often were too brief or characterized by inadequate dosing to be effective. A group of non-treatment resistant patients was matched for age, gender, and depressive subtype with 26 treatment-resistant patients. Treatment-resistant patients were less "atypical" and were more likely to have made a suicide attempt than the comparison patients. Although depression rating scales showed similar mean ratings for both groups, the TPQ revealed higher mean ratings for harm avoidance and lower mean ratings for novelty seeking for treatment-resistant patients. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629754     DOI: 10.1016/0022-3956(94)00042-p

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  9 in total

Review 1.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

2.  Advances in the Management of Treatment-Resistant Depression.

Authors:  Paul E Holtzheimer
Journal:  Focus (Am Psychiatr Publ)       Date:  2010

3.  Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought.

Authors:  Peter Rabins; Brian S Appleby; Jason Brandt; Mahlon R DeLong; Laura B Dunn; Loes Gabriëls; Benjamin D Greenberg; Suzanne N Haber; Paul E Holtzheimer; Zoltan Mari; Helen S Mayberg; Evelyn McCann; Sallie P Mink; Steven Rasmussen; Thomas E Schlaepfer; Dorothy E Vawter; Jerrold L Vitek; John Walkup; Debra J H Mathews
Journal:  Arch Gen Psychiatry       Date:  2009-09

4.  Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression.

Authors:  Naji C Salloum; Maurizio Fava; Rebecca S Hock; Marlene P Freeman; Martina Flynn; Bettina Hoeppner; Cristina Cusin; Dan V Iosifescu; Madhukar H Trivedi; Gerard Sanacora; Sanjay J Mathew; Charles Debattista; Dawn F Ionescu; George I Papakostas
Journal:  J Affect Disord       Date:  2019-09-03       Impact factor: 4.839

Review 5.  The relevance of personality assessment in estimating the risk of onset and the outcome of major depressive disorder.

Authors:  Bogdan Nemes; Doina Cozman
Journal:  Clujul Med       Date:  2016-04-15

6.  Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder.

Authors:  Jan Prasko; Marie Ociskova; Ales Grambal; Zuzana Sigmundova; Petra Kasalova; Marketa Marackova; Michaela Holubova; Kristyna Vrbova; Klara Latalova; Milos Slepecky
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-07       Impact factor: 2.570

7.  Personality traits as risk factors for treatment-resistant depression.

Authors:  Michio Takahashi; Yukihiko Shirayama; Katsumasa Muneoka; Masatoshi Suzuki; Koichi Sato; Kenji Hashimoto
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Standardisation framework for the Maudsley staging method for treatment resistance in depression.

Authors:  Abebaw Fekadu; Jacek G Donocik; Anthony J Cleare
Journal:  BMC Psychiatry       Date:  2018-04-11       Impact factor: 3.630

9.  The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

Authors:  Richard J Zeifman; Fernanda Palhano-Fontes; Jaime Hallak; Emerson Arcoverde; João Paulo Maia-Oliveira; Draulio B Araujo
Journal:  Front Pharmacol       Date:  2019-11-19       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.